Medication induced sleepwalking: A systematic review
Abstract
receptor, enhance serotonergic activity, or block the activity of noradrenaline at β receptors. The results also have implications for prescribers to consider sleepwalking as a potential adverse effect and ensure that: 1) the patient is educated about a safe sleep environment; 2) they are encouraged to report the onset or exacerbation of sleepwalking, and 3) alternative treatments are considered if sleepwalking occurs.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Zolpidem has a relatively high risk of inducing a NREM parasomnia episode, especially in predisposed subjects.
“While the Z-drug Zolpidem has a relatively high risk of inducing a NREM parasomnia episode [6,96,97], especially in predisposed subjects”
From Diagnosis and Management of NREM Sleep Parasomnias in Children and Adults (2023) · cites this paper as [6]
The citation lists haven’t been fetched yet
References 112 · Cited by 112
- Authors
- Stallman, H. M., Kohler, M., & White, J.
- Affiliations
- University of South Australia (AU)
- Corresponding author
- Stallman, Helen M.
- Venue
- Sleep Medicine Reviews
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 37
- Pages
- 105-113
- ISSN
- 1087-0792 (ISSN-L)
- OpenAlex
- W2581728693
- Cited by
- 112
- References
- 112
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 12 · 2023: 20 · 2022: 15 · 2021: 17 · 2020: 16 · 2019: 9 · 2018: 6 · 2017: 2 · 2016: 2
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Sleep Medicine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- UniSA Research Outputs Repository (University of South Australia) (submittedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- sleepwalking, adverse drug reactions, benzodiazepines, selective serotonin reuptake inhibitors, beta-blockers, patient education, drug safety
- MeSH terms
- Zolpidem, Antidepressive Agents, Humans, Pyridines, Somnambulism, GABA-A Receptor Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
